1，2，4-𫫇二唑类衍生物的设计、合成及抗菌活性

doi:10.11949/0438-1157.20221365

摘要/Abstract

摘要：

大豆锈病是危害大豆生产的主要真菌病害。为了研发新型高效的杀菌剂，以N-(4-(5-(三氟甲基)-1，2，4-𫫇二唑-3-基)苯基)环丙甲酰胺为先导化合物，采用结构修饰的方法，引入新的取代基，以此设计了12个新型1，2，4-𫫇二唑类衍生物，通过肟化、合环、还原及缩合反应，合成得到，经¹H NMR和ESI-MS确证化学结构。测试了它们对大豆锈病的抗菌活性：当质量浓度为3.125 mg/L时，化合物5b、5d、6a、6e和6g对大豆锈病的抑制率分别为60%、65%、100%、98%和95%，优于对照药剂苯醚甲环唑(50%)；化合物6a抗菌活性优异，当质量浓度为0.39125 mg/L时，对大豆锈病仍有90%抑制率。分子对接的结果说明，化合物6a与组蛋白去乙酰化酶4(HDAC 4)和组蛋白去乙酰化酶7(HDAC 7)有着多种相互作用。

关键词: 大豆锈病, 1, 2, 4-??二唑, 设计, 反应, 合成, 抗菌活性, 分子对接

Abstract:

Soybean rust is one of the main fungal diseases affecting soybean production. To develop novel and highly effective fungicide, N-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)cyclopropanecarboxamide was used as the lead compound. Using the method of structural modification and introducing new substituents, 12 new 1,2,4-oxadiazole derivatives were designed, synthesized through oximation, ring closure, reduction and condensation reactions. Their chemical structures were characterized by ¹H NMR and ESI-MS. The bioassay results showed that the inhibition rates of compounds 5b, 5d, 6a, 6e and 6g against soybean rust at the concentration of 3.125 mg/L were 60%, 65%, 100%, 98% and 95%, respectively. The activities were all better than that of control agent difenoconazole (50%). Compound 6a displayed prominent anti-fungal activity. When the mass concentration was 0.39125 mg/L, it still had 90% inhibition rate against soybean rust. The molecular docking results showed that compound 6a had various interactions with histone deacetylase 4(HDAC4) and histone deacetylase 7(HDAC7).

Key words: soybean rust, 1,2,4-oxadiazole, design, reaction, synthesis, anti-fungal activity, molecular docking

中图分类号:

TQ 455.4

王锋, 陈钰, 裴鸿艳, 刘东东, 张静, 张立新. 1，2，4-𫫇二唑类衍生物的设计、合成及抗菌活性[J]. 化工学报, 2023, 74(3): 1390-1398.

Feng WANG, Yu CHEN, Hongyan PEI, Dongdong LIU, Jing ZHANG, Lixin ZHANG. Design, synthesis and anti-fungal activity of 1,2,4-oxadiazole derivatives[J]. CIESC Journal, 2023, 74(3): 1390-1398.

图/表 11

参考文献 32

1	Li D D, Zhang S S, Song Z H, et al. Bioactivity-guided mixed synthesis accelerate the serendipity in lead optimization: discovery of fungicidal homodrimanyl amides[J]. Eur. J. Med. Chem., 2017, 136: 114-121.
2	Wang L L, Li C, Zhang Y Y, et al. Synthesis and biological evaluation of benzofuroxan derivatives as fungicides against phytopathogenic fungi[J]. J. Agr. Food. Chem., 2013, 61(36): 8632-8640.
3	Price C L, Parker J E, Warrilow A G S, et al. Azole fungicides— understanding resistance mechanisms in agricultural fungal pathogens[J]. Pest. Manag. Sci., 2015, 71(8): 1054-1058.
4	李琼, 张晓明. 病虫害对5个大豆主产国大豆产量影响的概述[J]. 农学学报, 2018, 8(4): 23-27.
	Li Q, Zhang X M. Effect of diseases and insect pests on soybean yield in the top five soybean producing countries: a review [J]. Journal of Agriculture, 2018, 8(4): 23-27.
5	Phillips McDougall AgriServicer, Inc. Crops Section 2017 Market[EB/OL]. [2019-02-06]. .
6	刘梦竹, 裴鸿艳, 张静, 等. 大豆锈病防治药剂研究进展[J]. 现代农药, 2020, 19(6): 11-21.
	Liu M Z, Pei H Y, Zhang J, et al. Research progress of fungicides for soybean rust[J]. Modern Agrochemicals, 2020, 19(6): 11-21.
7	Stimson L, Wood V, Khan O, et al. HDAC inhibitor-based therapies and haematological malignancy[J]. Ann. Oncol., 2009, 20(8): 1293-1302.
8	张琳. CDKs/HDACs双靶点抑制剂T-17的抗肿瘤药效学研究[D]. 重庆: 重庆医科大学, 2021.
	Zhang L. The anticancer pharmacodynamics of the T-17, a dual target inhibitor of CDKs and HDACs[D]. Chongqing: Chongqing Medical University, 2021.
9	Winter C, Fehr M. Discovery of the trifluoromethyloxadiazoles—a new class of fungicides with a novel mode-of-action[M]// Recent Highlights in the Discovery and Optimization of Crop Protection Products. Amsterdam: Elsevier, 2021: 401-423.
10	Khan I, Ibrar A, Abbas N, et al. Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications[J]. Eur. J. Med.Chem., 2014, 76: 193-244.
11	Fan Z J, Shi J, Bao X P. Synthesis and antimicrobial evaluation of novel 1,2,4-triazole thioether derivatives bearing a quinazoline moiety[J]. Mol. Divers., 2018, 22: 657-667.
12	刘瑶, 李珊, 裘旎, 等. 3-芳基-5-吡唑基-1,2,4-𫫇二唑类HIF-1抑制剂的结构优化与构效关系研究[J]. 中国现代应用药学, 2021, 38(10): 1153-1160.
	Liu Y, Li S, Qiu N, et al. Structural modification and SAR study of 3-aryl-5-pyrazol-1,2,4-oxadiazole derivatives as HlF-1 inhibitor[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(10): 1153-1160.
13	Eleutherakis-papaiakovou E, Kanellias N, Kastritis E, et al. Efficacy of panobinostat for the treatment of multiple myeloma[J]. J. Oncol., 2020, 2020: 7131802.
14	Nazir M, Abbasi M A, Rehman A, et al. New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: as potent anti-diabetic agents[J]. Bioorg. Chem., 2018, 81: 253-263.
15	崔建国,庞丽萍,刘畅, 等. 某些具有吡唑和1,2,4-二唑支链的杂环甾体化合物的合成、表征及抗肿瘤活性评价(英文)[J]. 化学试剂, 2018, 40(7): 612-622.
	Cui J G, Pang L P, Liu C, et al. Synthesis,characterization and antiproliferative evaluation of some heterosteroids possessing side chain of pyrazoles or 1,2,4-oxadiazoles[J]. Chemical Reagents, 2018, 40(7): 612-622.
16	刘斌, 徐小娜, 朱周静, 等. N-[2,6-二氯-4-(1,2,4-𫫇二唑-3-基)苯基]-2-甲氧基烟酰胺的合成、晶体结构及抗肿瘤活性研究[J]. 化学通报, 2021, 84(4): 383-387, 399, 289.
	Liu B, Xu X N, Zhu Z J, et al. Synthesis,crystal structure and antitumor activity of N-(2,6-dichloro-4-(1,2,4-oxadiazol-3-yl) phenyl)-2-methoxynicotinamide[J]. Chem. Bull., 2021, 84(4): 383-387, 399, 289.
17	章乐天, 苏嘉媛, 徐晓勇. 作为杀菌和杀虫先导的1,2,4-𫫇二嗪衍生物的设计与合成研究[J]. 有机化学, 2021, 41(9): 3539-3549.
	Zhang L T, Su J Y, Xu X Y. Design and synthesis of 1,2,4-oxadiazine derivatives as promising fungicide and insecticide lead compound[J]. Chin. J. Org. Chem., 2021, 41(9): 3539-3549.
18	朱灵志. 含1,3,4-𫫇(噻)二唑或吡啶结构的1,2,4-𫫇二唑衍生物的设计合成及生物活性研究[D]. 贵阳: 贵州大学, 2021.
	Zhu L Z. Design, synthesis and biological activity of 1,2,4-oxadiazole derivatives containing 1,3,4-oxadiazole or pyridine structures [D]. Guiyang: Guizhou University, 2021.
19	孙鉴昕, 王将, 冯梦静, 等. 新型含1,2,4-𫫇二唑结构的酰胺类化合物的设计、合成及生物活性[J]. 山东化工,2021, 50(18): 42-44, 50.
	Sun J X, Wang J, Feng M J, et al. Design,synthesis and biological activity of novel amides containing 1,2,4-oxadiazole[J]. Shandong Chemical Industry, 2021, 50(18): 42-44, 50.
20	戴红, 丁颖, 杜显超, 等. 新型含取代𫫇二唑结构的吡唑肟类化合物的合成与生物活性研究[J]. 有机化学, 2018, 38(7): 1755-1762.
	Dai H, Ding Y, Du X C, et al. Synthesis and biological activities of novel pyrazole oximes containing substituted oxadiazole moiety[J]. Chin. J. Org. Chem., 2018, 38(7): 1755-1762.
21	王锋, 刘东东, 朱晨, 等. Flufenoxadiazam的合成及生物活性[J]. 农药, 2022, 61(5): 326-328.
	Wang F, Liu D D, Zhu C, et al. Synthesis and fungicidal activity research of flufenoxadiazam[J]. Agrochemicals, 2022, 61(5): 326-328.
22	吴文能, 费强, 王瑞, 等. 5-嘧啶基1,2,4-𫫇二唑化合物的合成及抗菌活性研究[J]. 化学研究与应用, 2019, 31(2): 355-360.
	Wu W N, Fei Q, Wang R, et al. Synthesis and fungicidal activity of 5-pyrimidine 1,2,4-oxadiazole derivatives[J]. Chem. Res. Appl., 2019, 31(2): 355-360.
23	Dai H, Chen J, Li G, et al. Design, synthesis, and bioactivities of novel oxadiazole-substituted pyrazole oximes[J]. Bioorg. Med. Chem. Lett., 2017, 27(4): 950-953.
24	陈东亮, 初文毅, 鄢明. 1,2,4-𫫇二唑类化合物的合成及抗菌活性研究[J]. 化学研究与应用, 2010, 22(2): 176-181.
	Chen D L, Chu W Y, Yan M. Synthesis and antibacterial activity of 1,2,4-oxadiazole derivatives[J]. Chem. Res. Appl., 2010, 22(2): 176-181.
25	田克情, 刘晓欣, 王娇, 等. 含𫫇二唑环的1,5-苯并硫氮杂卓衍生物的合成及抑菌活性研究[J]. 化学试剂, 2015, 37(7): 608-612.
	Tian K Q, Liu X X, Wang J, et al. Synthesis and antibacterical properties of 1,5-benzothiazepine derivatives containing oxadiazolo[J]. Chemical Reagents, 2015, 37(7): 608-612.
26	张霁, 金传飞, 张英俊. 含氟药物研究进展和芳(杂)环氟化及N(n=1,2,3)氟甲基化新方法[J]. 有机化学, 2014, 34(4): 662-680.
	Zhang J, Jin C F, Zhang Y J. Recent advances in research and development of fluorinated drugs and new methods for fluorination, mono-, di- and tri-fluoromethylation[J]. Chin. J. Org. Chem., 2014, 34(4): 662-680.
27	刘华铮. 基于δ-三氟甲基对亚甲基苯醌的1,6-共轭加成合成有机叠氮化合物的研究[D]. 泰安: 山东农业大学, 2021.
	Liu H Z. Research on synthesis of organic azides by 1,6-conjugation addition of δ-CF₃-p-QMs[D]. Taian: Shandong Agricultural University, 2021.
28	Isanbor C, O'Hagan D, Tommasini M, et al. Fluorine in medicinal chemistry: a review of anti-cancer agents[J]. J. Fluorine. Chem., 2006, 127(3): 303-319.
29	Hoffman T J, Stierli D. Microbiocidal oxadiazole derivatives: US10757941[P]. 2020-09-01.
30	Wieja A, Winter C, Rosenbaum C, et al. Use of substituted oxadiazoles for combating phytopathogenic fungi: US10118906[P]. 2018-11-06.
31	Gonzalez E C, Munoz A O, Solana J S. 1,2,4-Oxadiazole derivatives as histone deacetylase 6 inhibitors: US20200339569[P]. 2020-10-29.
32	曹冉, 李伟, 孙汉资, 等. 计算化学方法在基于受体结构的药物分子设计中的基础理论及应用[J]. 药学学报, 2013, 48(7): 1041-1052.
	Cao R, Li W, Sun H Z, et al. Computational chemistry in structure-based drug design[J]. Acta Pharm. Sin., 2013, 48(7): 1041-1052.

Compound	Reaction time/h	Feature	Melting point/℃	Yield/%	m/z (calcd.)^①
5a	4.0	white solid	185.2—185.9	75.65	340.1(340.1)
5b	4.0	white solid	188.2—189.0	78.25	354.1(354.1)
5c	3.5	yellow solid	184.6—185.2	76.52	368.1(368.1)
5d	5.0	yellow oil	—	70.26	352.2(352.1)
5e	5.0	white solid	189.6—190.1	72.24	370.1(370.1)

Compound	Reaction time/h	Feature	Melting point/℃	Yield/%	m/z (calcd.)^①
5a	4.0	white solid	185.2—185.9	75.65	340.1(340.1)
5b	4.0	white solid	188.2—189.0	78.25	354.1(354.1)
5c	3.5	yellow solid	184.6—185.2	76.52	368.1(368.1)
5d	5.0	yellow oil	—	70.26	352.2(352.1)
5e	5.0	white solid	189.6—190.1	72.24	370.1(370.1)

Compound	δ
5a	8.23 (d, J = 8.5 Hz, 2H, Ph-2H), 7.39 (d, J = 8.5 Hz, 2H, Ph-2H), 2.51 (s, 3H, CH₃), 1.63—1.59 (m, 1H, CH), 1.18—1.11 (m, 2H, half-CH₂CH₂), 0.86—0.83 (m, 2H, half-CH₂CH₂)
5b	8.23 (d, J = 8.5 Hz, 2H, Ph-2H), 7.38 (d, J = 8.5 Hz, 2H, Ph-2H), 2.80 (q, J = 7.3 Hz, 2H, CH₂), 1.75—1.71 (m, 1H, CH), 1.17 (t, J = 7.3 Hz, 3H, CH₃), 1.15—1.12 (m, 2H, half-CH₂CH₂), 0.87—0.84 (m, 2H, half-CH₂CH₂)
5c	8.22 (d, J = 8.4 Hz, 2H, Ph-2H), 7.36 (d, J = 8.5 Hz, 2H, Ph-2H), 3.35—3.30 (m, 1H, CH), 1.74—1.70 (m, 1H, CH), 1.21[d, J = 6.8 Hz, 6H, (CH₃)₂], 1.17—1.14 (m, 2H, half-CH₂CH₂), 0.88—0.85 (m, 2H, half-CH₂CH₂)
5d	8.23 (d, J = 8.4 Hz, 2H, Ph-2H), 7.39 (d, J = 8.5 Hz, 2H, Ph-2H), 6.63 (dd, J = 16.8, 10.3 Hz, 1H, =CH), 6.48 (dd, J = 16.8, 1.6 Hz, 1H, CH), 5.78 (dd, J = 10.3, 1.6 Hz, 1H, =CH), 1.93—1.89 (m, 1H, CH), 1.21—1.18 (m, 2H, half-CH₂CH₂), 0.94—0.91 (m, 2H, half-CH₂CH₂)
5e	8.17 (d, J = 8.5 Hz, 2H, Ph-2H), 7.30 (d, J = 8.5 Hz, 2H, Ph-2H), 4.23 (q, J = 7.1 Hz, 2H, CH₂), 2.83—2.78 (m, 1H, CH), 1.20 (t, J = 7.1 Hz, 3H, CH₃), 1.19—1.16 (m, 2H, half-CH₂CH₂), 1.02—0.99 (m, 2H, half-CH₂CH₂)

Compound	δ
5a	8.23 (d, J = 8.5 Hz, 2H, Ph-2H), 7.39 (d, J = 8.5 Hz, 2H, Ph-2H), 2.51 (s, 3H, CH₃), 1.63—1.59 (m, 1H, CH), 1.18—1.11 (m, 2H, half-CH₂CH₂), 0.86—0.83 (m, 2H, half-CH₂CH₂)
5b	8.23 (d, J = 8.5 Hz, 2H, Ph-2H), 7.38 (d, J = 8.5 Hz, 2H, Ph-2H), 2.80 (q, J = 7.3 Hz, 2H, CH₂), 1.75—1.71 (m, 1H, CH), 1.17 (t, J = 7.3 Hz, 3H, CH₃), 1.15—1.12 (m, 2H, half-CH₂CH₂), 0.87—0.84 (m, 2H, half-CH₂CH₂)
5c	8.22 (d, J = 8.4 Hz, 2H, Ph-2H), 7.36 (d, J = 8.5 Hz, 2H, Ph-2H), 3.35—3.30 (m, 1H, CH), 1.74—1.70 (m, 1H, CH), 1.21[d, J = 6.8 Hz, 6H, (CH₃)₂], 1.17—1.14 (m, 2H, half-CH₂CH₂), 0.88—0.85 (m, 2H, half-CH₂CH₂)
5d	8.23 (d, J = 8.4 Hz, 2H, Ph-2H), 7.39 (d, J = 8.5 Hz, 2H, Ph-2H), 6.63 (dd, J = 16.8, 10.3 Hz, 1H, =CH), 6.48 (dd, J = 16.8, 1.6 Hz, 1H, CH), 5.78 (dd, J = 10.3, 1.6 Hz, 1H, =CH), 1.93—1.89 (m, 1H, CH), 1.21—1.18 (m, 2H, half-CH₂CH₂), 0.94—0.91 (m, 2H, half-CH₂CH₂)
5e	8.17 (d, J = 8.5 Hz, 2H, Ph-2H), 7.30 (d, J = 8.5 Hz, 2H, Ph-2H), 4.23 (q, J = 7.1 Hz, 2H, CH₂), 2.83—2.78 (m, 1H, CH), 1.20 (t, J = 7.1 Hz, 3H, CH₃), 1.19—1.16 (m, 2H, half-CH₂CH₂), 1.02—0.99 (m, 2H, half-CH₂CH₂)

Compound	Reaction time/h	Feature	Melting point/℃	Yield/%	m/z (calcd.)
6a	4.0	white solid	185.2—185.6	80.45	365.2(365.1)
6b	5.0	white solid	190.5—191.2	80.25	338.4(338.1)
6c	4.0	yellow solid	162.6—163.7	90.84	360.3(360.1)
6d	5.0	white solid	184.2—185.2	84.52	380.3(380.1)
6e	5.0	white solid	183.5—184.2	73.69	384.2(384.1)
6f	5.0	white solid	195.2—195.8	80.42	380.2(380.1)
6g	5.0	white solid	248.6—249.0	70.35	384.1(384.1)